NCT07339488
- Conditions
- Borderline Resectable Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +19 more
- Locations
-
- Cancer Hospital, Shantou University Medical College Shantou, Guangdong, China
Clinical trial condition
Borderline Resectable Carcinoma
Explore clinical trials studying Borderline Resectable Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Borderline Resectable Carcinoma trial results
Not Yet Recruiting
Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC
NCT06998719
- Conditions
- Borderline Resectable Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China